Trial Profile
A Pilot, Randomised Controlled Study to evaluate whether the administration of enteral Ivabradine plus standard care reduces tachycardia in critically ill adult patients with septic shock compared to standard care alone
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Corticosteroids; Vasopressors
- Indications Sinus tachycardia
- Focus Therapeutic Use
- 18 Oct 2018 New trial record